I. Sinkeviciute

发表

Efficacy of different types of cognitive enhancers for patients with schizophrenia: a meta-analysis

K. Hugdahl, B. Oranje, I. Sommer, 2018, npj Schizophrenia.

Ef fi cacy of different types of cognitive enhancers for patients with schizophrenia : a meta-analysis

K. Hugdahl, B. Oranje, I. Sommer, 2018 .

Training switching focus with a mobile-application by a patient suffering from AVH, a case report.

Josef J. Bless, I. Sommer, I. Sinkeviciute, 2018, Scandinavian journal of psychology.

Negative valence of hallucinatory voices as predictor of cortical glutamatergic metabolite levels in schizophrenia patients

K. Hugdahl, I. Sommer, K. Kompus, 2021, Brain and behavior.

Priapism in Antipsychotic Drug Use: A Rare but Important Side Effect

E. Johnsen, R. Kroken, I. Sinkeviciute, 2012, Case reports in psychiatry.

Hallucinations in acutely admitted patients with psychosis, and effectiveness of risperidone, olanzapine, quetiapine, and ziprasidone: a pragmatic, randomized study

K. Hugdahl, H. Jørgensen, E. Løberg, 2013, BMC Psychiatry.

Trajectories of depressive symptoms in the acute phase of psychosis: Implications for treatment.

H. Jørgensen, E. Løberg, E. Johnsen, 2018, Journal of psychiatric research.

Sex differences in antipsychotic efficacy and side effects in schizophrenia spectrum disorder: results from the BeSt InTro study

M. Rettenbacher, I. Sommer, S. Reitan, 2021, npj Schizophrenia.

Childhood trauma in schizophrenia spectrum disorders as compared to substance abuse disorders

M. Rettenbacher, J. Thimm, E. Løberg, 2018, Psychiatry Research.

The phenomenology of auditory verbal hallucinations in schizophrenia assessed with the MiniVoiceQuestionnaire (MVQ)

K. Hugdahl, M. Hirnstein, L. Ersland, 2023, medRxiv.

Differential Effectiveness of Atypical Antipsychotics on Hallucinations

K. Hugdahl, M. Rettenbacher, S. Reitan, 2021, Journal of clinical psychopharmacology.

Trajectories of Treatment Response in Hallucinations

K. Hugdahl, I. Sommer, H. Jørgensen, 2019, Neuropsychiatry.

Suicidality in Schizophrenia Spectrum Disorders: The Relationship to Hallucinations and Persecutory Delusions

K. Hugdahl, H. Jørgensen, E. Løberg, 2015, European Psychiatry.

Amisulpride, aripiprazole, and olanzapine in patients with schizophrenia-spectrum disorders (BeSt InTro): a pragmatic, rater-blind, semi-randomised trial.

K. Hugdahl, V. Steen, M. Rettenbacher, 2020, The lancet. Psychiatry.

Mapping psychotic-like experiences: Results from an online survey.

K. Hugdahl, I. Sommer, F. Larøi, 2020, Scandinavian journal of psychology.

Personality and Social Psychology Mapping psychotic-like experiences: Results from an online survey

K. Hugdahl, I. Sommer, M. Hirnstein, 2021 .

Different response patterns in hallucinations and delusions to antipsychotic treatment

H. Jørgensen, E. Løberg, E. Johnsen, 2020, Nordic journal of psychiatry.

The Beliefs about Voices Questionnaire – Revised: A factor structure from 450 participants

K. Hugdahl, F. Waters, A. Asbjørnsen, 2018, Psychiatry Research.

Antidepressive Effectiveness of Amisulpride, Aripiprazole, and Olanzapine in Patients With Schizophrenia Spectrum Disorders

M. Rettenbacher, S. Reitan, I. Joa, 2023, Journal of clinical psychopharmacology.

Does drug use affect the efficacy of amisulpride, aripiprazole and olanzapine in patients with schizophrenia spectrum disorders? Results from a pragmatic, randomised study.

M. Rettenbacher, S. Reitan, I. Joa, 2023, General hospital psychiatry.

Reply to a Letter to the Editors From Dr de Souza and colleagues: "Unraveling the Optimal Treatment Approach for Depression in Schizophrenia Spectrum: A Quest for Clarity".

M. Rettenbacher, S. Reitan, E. Løberg, 2024, Journal of clinical psychopharmacology.